World Congress on Biologics and Biosimilars

The  International Conference on Biosimilars & Pharmaceuticals hosted by conference series with was successfully executed during Feb 28-March 01, 2019 in Osaka, Japan. The conference offered a unique opportunity to investigators across the globe in order to meet, explore, network and perceive new scientific innovations. The conference received commendable and active participation was received from the Editorial Board Members of OMICS Group Journals as well as from the global scientists, Professors, Academicians, Researcher Scholars and students from diverse fields of Plant Science and Bio-Technology.

The conference commenced with the presence of a worthy Keynote forum and among the notable ones, few are listed below.

  • Leading the development of biosimilars, biobetters, and biologics that have received regulatory approval in highly-regulated markets around the world” by Dr. Peter Kalinka, Chairman at Longmore 60 Biotech Inc. Longmore 60 Biotech Inc.United States 

Conferenceseries is organizing “World Congress on Biologics and Biosimilars” which is going to be held on November 16-17, 2020 in Kyoto, Japan. The delight of attending Biologics meet 2020 will empower us to continue plunging further into both the examination of Biosimilar change and the business necessities for associations. Biologics meet 2020 is the platform where you can meet scientists, authorities, and CROs from around the world.

The conference highlights of 2020 are as follows: Developing Biosimilars & Biobetters, Challenges in Biosimilars Intellectual Property Rights, Bioequivalence Assessment, Biological Medicines, Emerging Biosimilars in Therapeutics, Innovative Approaches for Biosimilars, Regulatory Advances in Biosimilars, Biosimilars Market Strategy, Biosimilars Approval to Biogenerics in Clinical Practice, Biopharmaceutical Consequences of Brexit on Biosimilars, BCS & IVIVC Based Biowaivers, Pharmacovigilance Challenges, and SafetyProgram Manager.